- About Overview
- Diversity, Equity, and Inclusion
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Dean’s Office
- Dean’s Office Overview
- Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Org Chart
- Patient Care
Kroetz discusses pharmacogenomics on KQED Quest radio
By UCSF School of Pharmacy Editorial Staff / Fri Oct 16, 2009
UCSF researcher Deanna Kroetz, PhD, discusses the impact of genetic differences on how an individual responds to drugs in a KQED Quest radio interview that aired September 14, 2009. Fellow members of the interview panel were UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, and UCSF breast cancer surgeon Laura Esserman, MD, MBA.
Pharmacogenomics is a major research focus in Kroetz's home Department of Bioengineering and Therapeutic Sciences, which is a joint department between the UCSF Schools of Pharmacy and Medicine. The goal is safer, more effective therapies for populations and individuals. Making the promise of pharmacogenomics a reality for patients is a major strategic goal of the UCSF School of Pharmacy.
Personalized Medicine, KQED Quest, September 14, 2009.- 5 min. 42 sec.
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.